BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31625692)

  • 1. Identification of chlorprothixene as a potential drug that induces apoptosis and autophagic cell death in acute myeloid leukemia cells.
    Du Y; Li K; Wang X; Kaushik AC; Junaid M; Wei D
    FEBS J; 2020 Apr; 287(8):1645-1665. PubMed ID: 31625692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyphyllin I Inhibits Proliferation and Induces Apoptosis by Downregulating AML1-ETO and Suppressing C-KIT/Akt Signaling in t(8;21) Acute Myeloid Leukemia.
    Chai Y; Si Y; Xu J; Xiang Y; Zhao H; Si Y; Zhang T; Liu Y
    Chem Biodivers; 2018 Nov; 15(11):e1800314. PubMed ID: 30194712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T315 Decreases Acute Myeloid Leukemia Cell Viability through a Combination of Apoptosis Induction and Autophagic Cell Death.
    Chiu CF; Weng JR; Jadhav A; Wu CY; Sargeant AM; Bai LY
    Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27537872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting PDK1 with dichloroacetophenone to inhibit acute myeloid leukemia (AML) cell growth.
    Qin L; Tian Y; Yu Z; Shi D; Wang J; Zhang C; Peng R; Chen X; Liu C; Chen Y; Huang W; Deng W
    Oncotarget; 2016 Jan; 7(2):1395-407. PubMed ID: 26593251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sertraline exerts its antitumor functions through both apoptosis and autophagy pathways in acute myeloid leukemia cells.
    Xia D; Zhang YT; Xu GP; Yan WW; Pan XR; Tong JH
    Leuk Lymphoma; 2017 Sep; 58(9):1-10. PubMed ID: 28278721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell Cycle Arrest and Apoptosis Induction Activity of Nitidine Chloride on Acute Myeloid Leukemia Cells.
    Li P; Yan S; Dong X; Li Z; Qiu Y; Ji C; Zhang J; Ji M; Li W; Wang H; Liu Z; Wang XL; Ye J; Ma D
    Med Chem; 2018; 14(1):60-66. PubMed ID: 28629311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A synthetic cell-penetrating peptide derived from nuclear localization signal of EPS8 exerts anticancer activity against acute myeloid leukemia.
    Chen Y; Xie X; Wu A; Wang L; Hu Y; Zhang H; Li Y
    J Exp Clin Cancer Res; 2018 Jan; 37(1):12. PubMed ID: 29357910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OSU-A9, an indole-3-carbinol derivative, induces cytotoxicity in acute myeloid leukemia through reactive oxygen species-mediated apoptosis.
    Bai LY; Weng JR; Chiu CF; Wu CY; Yeh SP; Sargeant AM; Lin PH; Liao YM
    Biochem Pharmacol; 2013 Nov; 86(10):1430-40. PubMed ID: 24041743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aprepitant Sensitizes Acute Myeloid Leukemia Cells to the Cytotoxic Effects of Cytosine Arabinoside in vitro and in vivo.
    Wu H; Cheng X; Huang F; Shao G; Meng Y; Wang L; Wang T; Jia X; Yang T; Wang X; Fu C
    Drug Des Devel Ther; 2020; 14():2413-2422. PubMed ID: 32606608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TXNIP induces growth arrest and enhances ABT263-induced apoptosis in mixed-lineage leukemia-rearranged acute myeloid leukemia cells.
    Noura M; Matsuo H; Koyama A; Adachi S; Masutani H
    FEBS Open Bio; 2020 Aug; 10(8):1532-1541. PubMed ID: 32511893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radotinib inhibits acute myeloid leukemia cell proliferation via induction of mitochondrial-dependent apoptosis and CDK inhibitors.
    Heo SK; Noh EK; Gwon GD; Kim JY; Jo JC; Choi Y; Koh S; Baek JH; Min YJ; Kim H
    Eur J Pharmacol; 2016 Oct; 789():280-290. PubMed ID: 27477352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The small-molecule compound AC-73 targeting CD147 inhibits leukemic cell proliferation, induces autophagy and increases the chemotherapeutic sensitivity of acute myeloid leukemia cells.
    Spinello I; Saulle E; Quaranta MT; Pasquini L; Pelosi E; Castelli G; Ottone T; Voso MT; Testa U; Labbaye C
    Haematologica; 2019 May; 104(5):973-985. PubMed ID: 30467201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imidazoquinoxaline derivative EAPB0503: A promising drug targeting mutant nucleophosmin 1 in acute myeloid leukemia.
    Nabbouh AI; Hleihel RS; Saliba JL; Karam MM; Hamie MH; Wu HJM; Berthier CP; Tawil NM; Bonnet PA; Deleuze-Masquefa C; El Hajj HA
    Cancer; 2017 May; 123(9):1662-1673. PubMed ID: 28055106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BPR1J373, an Oral Multiple Tyrosine Kinase Inhibitor, Targets c-KIT for the Treatment of c-KIT-Driven Myeloid Leukemia.
    Chen LT; Chen CT; Jiaang WT; Chen TY; Butterfield JH; Shih NY; Hsu JT; Lin HY; Lin SF; Tsai HJ
    Mol Cancer Ther; 2016 Oct; 15(10):2323-2333. PubMed ID: 27512117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disruption of Wnt/β-Catenin Exerts Antileukemia Activity and Synergizes with FLT3 Inhibition in
    Jiang X; Mak PY; Mu H; Tao W; Mak DH; Kornblau S; Zhang Q; Ruvolo P; Burks JK; Zhang W; McQueen T; Pan R; Zhou H; Konopleva M; Cortes J; Liu Q; Andreeff M; Carter BZ
    Clin Cancer Res; 2018 May; 24(10):2417-2429. PubMed ID: 29463558
    [No Abstract]   [Full Text] [Related]  

  • 16. The simultaneous inhibition of the mTOR and MAPK pathways with Gnetin-C induces apoptosis in acute myeloid leukemia.
    Espinoza JL; Elbadry MI; Taniwaki M; Harada K; Trung LQ; Nakagawa N; Takami A; Ishiyama K; Yamauchi T; Takenaka K; Nakao S
    Cancer Lett; 2017 Aug; 400():127-136. PubMed ID: 28456658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of N822K T>A mutation-induced constitutive c-KIT activation in AML cells triggers apoptotic and autophagic pathways leading to death.
    Xu J; Zheng J; Fu X; Wu W; Tao L; Li D; Lin D
    Int J Med Sci; 2019; 16(5):757-765. PubMed ID: 31217744
    [No Abstract]   [Full Text] [Related]  

  • 18. Duocarmycin SA Reduces Proliferation and Increases Apoptosis in Acute Myeloid Leukemia Cells In Vitro.
    Chen WA; Williams TG; So L; Drew N; Fang J; Ochoa P; Nguyen N; Jawhar Y; Otiji J; Duerksen-Hughes PJ; Reeves ME; Casiano CA; Jin H; Dovat S; Yang J; Boyle KE; Francis-Boyle OL
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of the hypoxia-activated prodrug, TH-302, in preclinical human acute myeloid leukemia models.
    Portwood S; Lal D; Hsu YC; Vargas R; Johnson MK; Wetzler M; Hart CP; Wang ES
    Clin Cancer Res; 2013 Dec; 19(23):6506-19. PubMed ID: 24088735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel application of furazolidone: anti-leukemic activity in acute myeloid leukemia.
    Jiang X; Sun L; Qiu JJ; Sun X; Li S; Wang X; So CW; Dong S
    PLoS One; 2013; 8(8):e72335. PubMed ID: 23951311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.